Communicating end of trial results to participants
A suggested process for communicating end of trial results to people who took part in a typical antimalarial drug trial
Publication Version
v1.0
Publication Code
AD13
It is considered good practice to thank and communicate trial results to the participants who took part in a trial. This document therefore describes a process for undertaking this task in a typical antimalarial drug trial after the trial is finished.